We are live on
!
Find out more
MP
MFN Partners Portfolio holdings
AUM
$4.77B
1-Year Est. Return
72.29%
This Fund
S&P 500
This Quarter
Est. Return
+32.92%
1 Year Est. Return
+72.29%
3 Year Est. Return
+200.41%
5 Year Est. Return
+244.77%
10 Year Est. Return
–
AUM
$3.08B
AUM Growth
+$867M
(+39%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
5.38%
Top 10 Holdings %
Top 10 Hldgs %
97.16%
Holding
16
New
1
Increased
–
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Citizens BancShares
FCNCA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PAR Technology
PAR
|
+$20.4M |
| 2 |
Constellation Energy
CEG
|
+$17.7M |
| 3 |
Cyclerion Therapeutics
CYCN
|
+$5 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 33.61% |
| 2 | Financials | 18.68% |
| 3 | Consumer Discretionary | 15.32% |
| 4 | Communication Services | 11.72% |
| 5 | Healthcare | 9.34% |
Similar funds
WAM
MF
CA
RC
GAM
JCM
SAMU
MFN Partners's Q2 2023 Portfolio in Review
As of Q2 2023, MFN Partners held 16 positions worth $3.08B, up 39% from $2.21B the previous quarter. Its ten largest holdings account for 97% of the portfolio.
MFN Partners deployed $166M of net new capital in Q2 2023, opening 1 new position. Its largest new stake was First Citizens BancShares: 200,000 shares worth $257M.
By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Cyclerion Therapeutics, an estimated $5 trimmed.
- MFN Partners's largest Q2 2023 buy was First Citizens BancShares: 200,000 shares worth $257M.
- MFN Partners's biggest Q2 2023 reduction was Cyclerion Therapeutics, cutting an estimated $5.
- MFN Partners fully exited PAR Technology in Q2 2023, selling an estimated $20.4M.
- MFN Partners's ten largest holdings make up 97% of its $3.08B portfolio in Q2 2023.
- MFN Partners opened 1 new position and closed 2 in Q2 2023.
- MFN Partners's portfolio value rose 39% quarter-over-quarter to $3.08B.
Based on MFN Partners's 13F filing for Q2 2023, filed 11 Aug 2023.